1 秘勇建，盖洁，江渔，等. 蛛网膜下腔出血后脑血管痉

挛发生机制及治疗的研究进展[J]. 中华脑血管病杂志

（电子版），2013，7：218-221.

2 Connolly ES Jr，Rabinstein AA，Carhuapoma JR，et al. Guidelines for the management of aneurysmal

subarachnoid hemorrhage：a guideline for healthcare

professionals from the American Heart Association/

american Stroke Association[J]. Stroke，2012，43：

1711-1737.

3 Rabi n s t e i n AA，La n z i no G，Wij d i ck s EF.

Multidisciplinary management and emerging

therapeutic strategies in aneurysmal subarachnoid

haemorrhage[J]. Lancet Neurol，2010，9：504-519.

4 Vatter H，Weidauer S，Konczalla J，et al. Time

course in the development of cerebral vasospasm

after experimental subarachnoid hemorrhage：clinical

and neuroradiological assessment of the rat double

hemorrhage model[J]. Neurosurgery，2006，58：1190-

1197.

5 Durrant JC，Hinson HE. Rescue therapy for refractory

vasospasm after subarachnoid hemorrhage[J]. Curr

Neurol Neurosci Rep，2015，15：521.

6 Dorsch NW. Cerebral arterial spasm--a clinical

review[J]. Br J Neurosurg，1995，9：403-412.

7 Raymond J，Darsaut TE，Kotowski M，e t a l.

Unruptured intracranial aneurysms：why clinicians

should not resort to epidemiologic studies to justify

interventions[J]. AJNR Am J Neuroradiol，2011，32：

1568-1569.

8 陈罡，杭春华. 蛛网膜下腔出血后脑血管痉挛的治疗

现状及临床进展[J]. 医学研究生学报，2006，19：569-

572.

9 Lin CL，Dumont AS，Zhang JH. Cerebral vasospasm

af ter aneurysmal subarachnoid hemor rhage：

mechanism and therapies[J]. 2014，2014：679014.

10 Link TE，Murakami K，Beem-Miller M，et al.

Oxyhemoglobin-induced expression of R-type Ca2+

channels in cerebral arteries[J]. Stroke，2008，39：

2122-2128.

11 Kim I，Leinweber BD，Morgalla M，et al. Thin

and thick filament regulation of contractility in

experimental cerebral vasospasm[J]. Neurosurgery，

2000，46：440-446.

12 Kassell NF，Haley EC Jr，Apperson-Hansen C，et

al. Randomized，double-blind，vehicle-controlled

trial of tirilazad mesylate in patients with aneurysmal

subarachnoid hemorrhage：a cooperative study in

Europe，Australia，and New Zealand[J]. J Neurosurg，

1996，84：221-228.

13 Fathi AR，Bakhtian KD，Pluta RM. The role of nitric

oxide donors in treating cerebral vasospasm after

subarachnoid hemorrhage[J]. Acta Neurochir Suppl，

2011，110：93-97.

14 Zhang ZW，Yanamoto H，Nagata I，et al. Plateletderived

growth factor-induced severe and chronic vasoconstriction of cerebral ar teries：proposed

growth factor explanation of cerebral vasospasm[J].

Neurosurgery，2010，66：728-735.

15 Harrod CG，Bendok BR，Batjer HH. Prediction

of cerebral vasospasm in patients presenting with

aneurysmal subarachnoid hemorrhage：a review[J].

Neurosurgery，2005，56：633-654.

16 Pluta RM. Delayed cerebral vasospasm and nitric

oxide：review，new hypothesis，and proposed

treatment[J]. Pharmacol Ther，2005，105：23-56.

17 Thampatty BP，Sherwood PR，Gallek MJ，et al. Role

of endothelin-1 in human aneurysmal subarachnoid

hemorrhage：associations with vasospasm and delayed

cerebral ischemia[J]. Neurocrit Care，2011，15：19-27.

18 Koskinen LO，Olivecrona M，Rodling-Wahlstrom M，

et al. Prostacyclin treatment normalises the MCA flow

velocity in nimodipine-resistant cerebral vasospasm

after aneurysmal subarachnoid haemorrhage：a pilot

study[J]. Acta Neurochir (Wien)，2009，151：595-599.

19 Ersahin M，Toklu HZ，Cetinel S，et al. Alpha

lipoic acid alleviates oxidative stress and preserves

blood brain permeability in rats with subarachnoid

hemorrhage[J]. Neurochem Res，2010，35：418-428.

20 Erdi MF，Guney O，Kiyici A，et al. The effects of

alpha lipoic acid on cerebral vasospasm following

experimental subarachnoid hemor rhage in the

rabbit[J]. Turk Neurosurg，2011，21：527-533.

21 Clat terbuck RE，Gailloud P，Tierney T，et al.

Controlled release of a nitric oxide donor for the

prevention of delayed cerebral vasospasm following

experimental subarachnoid hemorrhage in nonhuman

primates[J]. J Neurosurg，2005，103：745-751.

22 Provencio JJ，Vora N. Subarachnoid hemorrhage and

inflammation：bench to bedside and back[J]. Semin

Neurol，2005，25：435-444.

23 Schneider UC，Schiffler J，Hakiy N，et al. Functional

analysis of pro-inflammatory properties within the

cerebrospinal fluid after subarachnoid hemorrhage

in vivo and in vitro[J]. J Neuroinflammation，2012，9：

28.

24 Ni W，Gu YX，Song DL，et al. The relationship

between IL-6 in CSF and occurrence of vasospasm

after subarachnoid hemorrhage[J]. Acta Neurochir

Suppl，2011，110：203-208.

25 Ozaki I，Tani E，Ikemoto H，et al. Activation of

stress-activated protein kinase/c-Jun NH2-terminal

kinase and p38 kinase in calphostin C-induced

apoptosis requires caspase-3-like proteases but is

dispensable for cell death[J]. J Biol Chem，1999，274：

5310-5317.

26 Tsurutani H，Ohkuma H，Suzuki S. Effects of thrombin inhibitor on thrombin-related signal

transduction and cerebral vasospasm in the rabbit

subarachnoid hemorrhage model[J]. Stroke，2003，34：

1497-1500.

27 Bederson JB，Connolly ES Jr，Batjer HH，et al.

Guidelines for the management of aneurysmal

subarachnoid hemorrhage：a statement for healthcare

professionals from a special writing group of the

Stroke Council，American Heart Association[J].

Stroke，2009，40：994-1025.

28 Dankbaar JW，Slooter AJ，Rinkel GJ，et al. Effect of

different components of triple-H therapy on cerebral

perfusion in patients with aneurysmal subarachnoid

haemorrhage：a systematic review[J]. Crit Care，2010，

14：R23.

29 Athar MK，Levine JM. Treatment options for cerebral

vasospasm in aneurysmal subarachnoid hemorrhage[J].

Neurotherapeutics，2012，9：37-43.

30 Hirashima Y，Endo S，Kato R，et al. Prevention

of cerebrovasospasm following subarachnoid

hemorrhage in rabbits by the platelet-activating factor

antagonist，E5880[J]. J Neurosurg，1996，84：826-

830.

31 Linfante I，Delgado-Mederos R，Andreone V，et

al. Angiographic and hemodynamic effect of high

concentration of intra-arterial nicardipine in cerebral

vasospasm[J]. Neurosurgery，2008，63：1080-1086.

32 Romero CM，Morales D，Reccius A，et al. Milrinone

as a rescue therapy for symptomatic refractory

cerebral vasospasm in aneurysmal subarachnoid

hemorrhage[J]. Neurocrit Care，2009，11：165-171.

33 Macdonald RL，Higashida RT，Keller E，et al.

Clazosentan，an endothelin receptor antagonist，in

patients with aneurysmal subarachnoid haemorrhage

undergoing surgical cl ipping：a randomised，

double-blind，placebo-controlled phase 3 trial

(CONSCIOUS-2)[J]. Lancet Neurol，2011，10：618-

625.

34 Murahashi T，Kamiyama K，Hara K，et al. The

eff iciency of cilostazol for cerebral vasospasm

following subarachnoid hemorrhage[J]. No Shinkei

Geka，2013，41：393-400.

35 Chen T，Carter BS. Role of magnesium sulfate in

aneurysmal subarachnoid hemorrhage management：

A meta-analysis of controlled clinical trials[J]. Asian J

Neurosurg，2011，6：26-31.

36 Milburn JM，Moran CJ，Cross DT，3rd，et al.

Increase in diameters of vasospastic intracranial

arteries by intraarterial papaverine administration[J].

J Neurosurg，1998，88：38-42.

37 Tseng MY. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid

hemorrhage[J]. Neurocrit Care，2011，15：298-301.

38 Shekhtman OD，Eliava S，Belousova OB，et al.

Simvastatin efficacy in vasospasm treatment in

patients after aneurysm SAH[J]. Zh Vopr Neirokhir

Im N N Burdenko，2012，76：13-19.

39 Lynch JR，Wang H，Mcgirt MJ，et al. Simvastatin

reduces vasospasm after aneurysmal subarachnoid

hemorrhage：results of a pilot randomized clinical

trial[J]. Stroke，2005，36：2024-2026.

40 Tseng MY，Czosnyka M，Richards H，et al. Effects

of acute treatment with pravastatin on cerebral

vasospasm，autoregulation，and delayed ischemic

deficits after aneurysmal subarachnoid hemorrhage：

a phase II randomized placebo-controlled trial[J].

Stroke，2005，36：1627-1632.

41 Juszkat R，Jonczyk-Potoczna K，Stanislawska K，et

al. Endovascular treatment of an adolescent patient

with a ruptured intracranial aneurysm-case report and

review of literature[J]. Pol J Radiol，2015，80：10-12.

42 Dumont AS，Crowley RW，Monteith SJ，et al.

Endovascular treatment or neurosurgical clipping

of ruptured int racranial aneurysms：effect on

angiographic va sospasm，delayed i schemic

neurological deficit，cerebral infarction，and clinical

outcome[J]. Stroke，2010，41：2519-2524. 43 王嘉炜，高觉民，黄玉杰，等. 葛根素对动脉瘤性蛛网

膜下腔出血后脑血管痉挛相关血管活性因子的影响

[J]. 中国中西医结合杂志，2012，32：164-167.

44 B a r d u t z k y J，Wi t s c h J，J u t t l e r E ，e t a l .

EARLYDRAIN- outcome after early lumbar CSFdrainage

in aneurysmal subarachnoid hemorrhage：

study protocol for a randomized controlled trial[J].

Trials，2011，12：203.

45 Macdonald RL，Higashida RT，Keller E，et al.

Randomised trial of clazosentan，an endothelin

receptor antagonist，in patients with aneurysmal

subarachnoid hemor rhage undergoing surgical

clipping (CONSCIOUS-2)[J]. Acta Neurochir Suppl，

2013，115：27-31.

46 Polin RS，Coenen VA，Hansen CA，et al. Efficacy

of transluminal angioplasty for the management of

symptomatic cerebral vasospasm following aneurysmal

subarachnoid hemorrhage[J]. J Neurosurg，2000，92：

284-290.

47 Muroi C，Seule M，Mishima K，et al. Novel treatments

for vasospasm after subarachnoid hemorrhage[J]. Curr

Opin Crit Care，2012，18：119-126.

48 De Gans K，Nieuwkamp DJ，Rinkel GJ，et al. Timing

of aneurysm surgery in subarachnoid hemorrhage: a

systematic review of the literature[J]. Neurosurgery，

2002，50：336-340.